The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Congress

Rep. Mace Questions LGBT Activist During House Committee Hearing

Rep. Mace Questions LGBT Activist During House Committee Hearing
Rep Nancy Mace (R-S.C.) speaks with reporters in Washington on Oct. 21, 2021. Anna Moneymaker/Getty Images
Chase Smith
Chase Smith
12/14/2022|Updated: 12/15/2022
0:00
Rep. Nancy Mace (R-S.C.) questioned an LGBT activist over previous tweets targeting Supreme Court Justices during a House Oversight and Reform Committee hearing on Dec. 13.

Mace asked each witness if extremist rhetoric against government officials on social media is a threat to democracy. Witnesses responded in the affirmative, including transgender activist Alejandra Caraballo, a biological male that identifies as a female who works at Harvard Law School’s Cyberlaw Clinic. The congresswoman then presented poster boards featuring a series of Caraballo’s tweets calling for officials to be accosted.

Chase Smith
Chase Smith
Author
Chase is an award-winning journalist. He covers national politics for The Epoch Times. For news tips, send Chase an email at [email protected] or connect with him on X.
twitter
Author’s Selected Articles

Wisconsin Directs $10 Million in Federal Funds to Anti-Violence Grant Program

Dec 05, 2025
Wisconsin Directs $10 Million in Federal Funds to Anti-Violence Grant Program

Overperforming and Still Losing: What Tennessee’s Special Election Actually Shows

Dec 05, 2025
Overperforming and Still Losing: What Tennessee’s Special Election Actually Shows

Senate Democrats Seek 3-Year Extension of Affordable Care Act Premium Tax Credits

Dec 04, 2025
Senate Democrats Seek 3-Year Extension of Affordable Care Act Premium Tax Credits

Democrats Step Up Push to Extend ACA Subsidies as Deadline Nears

Dec 01, 2025
Democrats Step Up Push to Extend ACA Subsidies as Deadline Nears
Related Topics
congress
Rep. Nancy Mace
violent rhetoric
LGBTQ activist
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.